Tango Therapeutics receives Outperform rating as William Blair initiates coverage
TNGX•William Blair initiated coverage of Tango Therapeutics with an Outperform rating.
Related News
JPMorgan Chase cuts total voting rights in Aixtron to 6.31% from 6.99%
JPM•
Walker & Dunlop publishes update to financial calendar
WD•
Strategy faces MSCI ouster under new rules, billions in passive holdings at risk
MSTR•
Eidesvik Offshore secures Equinor contract extension for Viking Avant through 2027
EQNR•
Ironwood Pharmaceuticals appoints Tammi Gaskins as chief executive officer
IRWD•